Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis

This article updates the Calcium Hypothesis of Alzheimer's disease and brain aging on the basis of emerging evidence since 1994 (The present article, with the subtitle “New evidence for a central role of Ca2+ in neurodegeneration,” includes three appendices that provide context and further explanations for the rationale for the revisions in the updated hypothesis—the three appendices are as follows: Appendix I “Emerging concepts on potential pathogenic roles of [Ca2+],” Appendix II “Future studies to validate the central role of dysregulated [Ca2+] in neurodegeneration,” and Appendix III “Epilogue: towards a comprehensive hypothesis.”) (Marx J. Fresh evidence points to an old suspect: calcium. Science 2007; 318:384–385). The aim is not only to re‐evaluate the original key claims of the hypothesis with a critical eye but also to identify gaps in knowledge required to validate relevant claims and delineate additional studies and/or data that are needed. Some of the key challenges for this effort included examination of questions regarding (1) the temporal and spatial relationships of molecular mechanisms that regulate neuronal calcium ion (Ca2+), (2) the role of changes in concentration of calcium ion [Ca2+] in various subcellular compartments of neurons, (3) how alterations in Ca2+ signaling affect the performance of neurons under various conditions, ranging from optimal functioning in a healthy state to conditions of decline and deterioration in performance during aging and in disease, and (4) new ideas about the contributions of aging, genetic, and environmental factors to the causal relationships between dysregulation of [Ca2+] and the functioning of neurons (see Appendices I and II). The updated Calcium Hypothesis also includes revised postulates that are intended to promote further crucial experiments to confirm or reject the various predictions of the hypothesis (see Appendix III).

[1]  E. Rojas,et al.  The Ability of Amyloid β‐Protein [AβP (1–40)] to Form Ca2+ Channels Provides a Mechanism for Neuronal Death in Alzheimer's Disease , 1994 .

[2]  Wendy W. Wu,et al.  Biophysical alterations of hippocampal pyramidal neurons in learning, ageing and Alzheimer's disease , 2004, Ageing Research Reviews.

[3]  Z. Khachaturian Epilogue: Toward a Comprehensive Theory of Alzheimer's Disease‐Challenges, Caveats, and Parameters , 2000, Annals of the New York Academy of Sciences.

[4]  G. Small,et al.  The pathogenesis of Alzheimer's disease. , 1998, The Journal of clinical psychiatry.

[5]  B. Berkowitz,et al.  Testing the calcium hypothesis of aging in the rat hippocampus in vivo using manganese-enhanced MRI , 2014, Neurobiology of Aging.

[6]  E. Carafoli Calcium-mediated cellular signals: a story of failures. , 2004, Trends in biochemical sciences.

[7]  M. Mattson Pathways towards and away from Alzheimer's disease , 2004, Nature.

[8]  E. Blalock,et al.  Intranasal Insulin Improves Age-Related Cognitive Deficits and Reverses Electrophysiological Correlates of Brain Aging. , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[9]  L. Mucke,et al.  A network dysfunction perspective on neurodegenerative diseases , 2006, Nature.

[10]  Z. Khachaturian,et al.  Development of biomarkers to chart all Alzheimer’s disease stages: The royal road to cutting the therapeutic Gordian Knot , 2012, Alzheimer's & Dementia.

[11]  M. Michaelis,et al.  Oxidative inactivation of purified plasma membrane Ca2+-ATPase by hydrogen peroxide and protection by calmodulin. , 2003, Biochemistry.

[12]  Xinkun Wang,et al.  Functional Genomics of Brain Aging and Alzheimer’s Disease: Focus on Selective Neuronal Vulnerability , 2010, Current genomics.

[13]  Pierpaolo Pani,et al.  A network of reverberating neuronal populations encodes motor decision in macaque premotor cortex , 2009, BMC Neuroscience.

[14]  J. Marx Fresh Evidence Points to an Old Suspect: Calcium , 2007, Science.

[15]  O. Arancio,et al.  Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease. , 2008, The Journal of clinical investigation.

[16]  Ernesto Carafoli,et al.  Calcium signaling: A tale for all seasons , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H. Geerts,et al.  A strategy for developing new treatment paradigms for neuropsychiatric and neurocognitive symptoms in Alzheimer’s disease , 2013, Front. Pharmacol..

[18]  Kim N. Green,et al.  Linking Calcium to Aβ and Alzheimer's Disease , 2008, Neuron.

[19]  R. Nixon The calpains in aging and aging-related diseases , 2003, Ageing Research Reviews.

[20]  E. Masliah,et al.  Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability , 2016, Alzheimer's & Dementia.

[21]  Z. Khachaturian A Unifying Hypothesis on the Etiology of Alzheimer’s Disease , 1990 .

[22]  N. Porter,et al.  Hippocampal calcium dysregulation at the nexus of diabetes and brain aging. , 2013, European journal of pharmacology.

[23]  Olivier Thibault,et al.  Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store , 2007, Aging cell.

[24]  M. Mattson,et al.  Endoplasmic Reticulum Ca2+ Handling in Excitable Cells in Health and Disease , 2011, Pharmacological Reviews.

[25]  F. Pasquier,et al.  A Polymorphism in CALHM1 Influences Ca2+ Homeostasis, Aβ Levels, and Alzheimer's Disease Risk , 2008, Cell.

[26]  I. Bezprozvanny Calcium signaling and neurodegenerative diseases. , 2009, Trends in molecular medicine.

[27]  E. Masliah,et al.  Differential calcium alterations in animal models of neurodegenerative disease: Reversal by FK506 , 2015, Neuroscience.

[28]  Theodore W. Berger,et al.  Integrated Multiscale Modeling of the Nervous System: Predicting Changes in Hippocampal Network Activity by a Positive AMPA Receptor Modulator , 2011, IEEE Transactions on Biomedical Engineering.

[29]  Grace E. Stutzmann The Pathogenesis of Alzheimers Disease—Is It a Lifelong “Calciumopathy”? , 2007, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[30]  Ian Parker,et al.  Calcium Signaling and Amyloid Toxicity in Alzheimer Disease* , 2010, The Journal of Biological Chemistry.

[31]  M. Michaelis,et al.  Decreases in plasma membrane Ca2+‐ATPase in brain synaptic membrane rafts from aged rats , 2012, Journal of neurochemistry.

[32]  M. Mesulam,et al.  The Special Topics Section of Alzheimer's & Dementia , 2015, Alzheimer's & Dementia.

[33]  T. Wyss-Coray,et al.  Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. , 2012, Cold Spring Harbor perspectives in medicine.

[34]  A. Starkov,et al.  Portal to Alzheimer's disease , 2008, Nature Medicine.

[35]  Z. Khachaturian The role of calcium regulation in brain aging: reexamination of a hypothesis , 1989, Aging.

[36]  Z. Khachaturian Models and Modeling Systems in Alzheimer Disease Drug Discovery , 2002, Alzheimer disease and associated disorders.

[37]  Patrik L. Ståhl,et al.  Visualization and analysis of gene expression in tissue sections by spatial transcriptomics , 2016, Science.

[38]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[39]  Z. Khachaturian Calcium Hypothesis of Alzheimer's Disease and Brain Aging a , 1994, Annals of the New York Academy of Sciences.

[40]  R. Mrak,et al.  Common Inflammatory Mechanisms in Lewy Body Disease and Alzheimer Disease , 2007, Journal of neuropathology and experimental neurology.

[41]  P. Landfield ‘Increased calcium-current’ hypothesis of brain aging , 1987, Neurobiology of Aging.

[42]  M. Mattson Late-onset dementia: a mosaic of prototypical pathologies modifiable by diet and lifestyle , 2015, npj Aging and Mechanisms of Disease.

[43]  Ilya Bezprozvanny,et al.  Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease , 2008, Trends in Neurosciences.

[44]  M. Michaelis,et al.  Genomic and biochemical approaches in the discovery of mechanisms for selective neuronal vulnerability to oxidative stress , 2009, BMC Neuroscience.

[45]  C. Dobson,et al.  A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer’s disease , 2016, Science Advances.

[46]  E. Carafoli Historical review: mitochondria and calcium: ups and downs of an unusual relationship. , 2003, Trends in biochemical sciences.

[47]  Zaven S. Khachaturian,et al.  In silico modeling system: A national research resource for simulation of complex brain disorders , 2009, Alzheimer's & Dementia.

[48]  Xiongwei Zhu,et al.  Mitochondrial DNA oxidative damage and repair in aging and Alzheimer's disease. , 2013, Antioxidants & redox signaling.

[49]  R. Nixon,et al.  Disorders of lysosomal acidification—The emerging role of v-ATPase in aging and neurodegenerative disease , 2016, Ageing Research Reviews.

[50]  Z. Khachaturian Perspectives on Alzheimer's Disease: Past, Present and Future , 2012 .

[51]  E. Blalock,et al.  Effect of high-fat diet on metabolic indices, cognition, and neuronal physiology in aging F344 rats , 2013, Neurobiology of Aging.